文献速递认知障碍与谵妄多重用药老年综合评估

致口干药物对痴呆患者口腔健康的影响

The Effect of Xerostomic Medication on Oral Health in Persons With Dementia.
PubMed 文献 · J Am Med Dir Assoc · 2018-07-05

该纵向注册研究纳入34,037名痴呆患者,分析痴呆诊断前3年连续使用致口干药物与后续3年口腔治疗结局的关联。结果显示致口干药物数量与拔牙发生率呈剂量反应关系,而新增充填治疗和预防性操作无组间差异。提示对痴呆患者处方致口干药物需谨慎并加强定期口腔照护。

要点

  • 致口干药物使用数量越多,痴呆患者拔牙风险越高,呈剂量反应关系。
  • 致口干药物使用与新增牙体充填及预防性口腔操作无显著关联。
  • 痴呆患者处方致口干药物时应权衡风险,并保障定期口腔照护。

核心结论

  • 连续使用致口干药物可增加痴呆患者拔牙风险。
  • 研究强调对痴呆患者处方致口干药物需谨慎,并需要定期持续的口腔照护。

研究设计与样本

  • 基于人群的纵向注册研究,随访3年。
  • 数据提取自瑞典痴呆注册库(SveDem)、瑞典处方药注册库(SPDR)、瑞典国家患者注册库(SNPR)和牙科健康注册库(DHR)。
  • 参与者为确诊痴呆时登记于SveDem的痴呆患者,共34,037人纳入分析。
  • 暴露为痴呆诊断前3年内连续使用致口干药物,结局为拔牙、牙体充填和牙科预防操作的发生率,采用泊松回归估计发病率比(IRR)并校正相关混杂因素。

主要发现

  • 共34,037名痴呆患者纳入分析。
  • 致口干药物使用与拔牙之间存在剂量反应关系。
  • 与未使用者相比,平均使用>0-1、>1-3和>3种致口干药物者的拔牙率IRR分别为1.03、1.11和1.40。
  • 各组间新增牙体充填治疗和接受预防性操作的风险无差异。

关键数值与推荐

  • 平均使用>0-1种致口干药物者拔牙IRR=1.03。
  • 平均使用>1-3种致口干药物者拔牙IRR=1.11。
  • 平均使用>3种致口干药物者拔牙IRR=1.40。

临床怎么用

  • 对痴呆患者处方致口干药物时应审慎评估,尤其当多种致口干药物联用时。
  • 应重视痴呆患者的定期和持续口腔照护,以降低拔牙风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Medication-induced hyposalivation can increase the risk for oral complications, including dental caries and tooth loss. This problem is particularly important in people with dementia because of their declining ability to maintain oral care. The objective of this study was to describe the association between the number of xerostomic medications used and tooth loss and restorative and dental preventive treatment in a population of persons with dementia. DESIGN: A longitudinal population-based register study with a 3-year follow-up was conducted. Data were extracted from the Swedish Dementia Registry (SveDem), the Swedish Prescribed Drug Register (SPDR), the Swedish National Patient Register (SNPR), and the Dental Health Register (DHR). SETTING AND PARTICIPANTS: Participants were persons with dementia who were registered in the SveDem at the time of their dementia diagnosis. MEASURES: The exposure was continuous use of xerostomic medications over the 3 years prior to dementia diagnosis (baseline). The outcomes were the incidence of tooth extractions, tooth restorations, and dental preventive procedures. Poisson regression models were used to estimate incidence rate ratios (IRRs) for the association between the exposure and outcomes, adjusting for relevant confounders. RESULTS: A total of 34,037 persons were included in the analysis. A dose-response relationship between the exposure and tooth extractions was observed. Compared with nonusers of xerostomic medication, the rate of tooth extractions increased with increasing number of xerostomic medications used (IRR = 1.03, 1.11, and 1.40 for persons using an average >0-1, >1-3, and >3 xerostomic medications, respectively). However, the risk for having new dental restorations and receiving preventive procedures did not differ between groups. CONCLUSION: Continuous use of xerostomic medications can increase the risk for tooth extraction in people with dementia. This study highlights the importance of careful consideration when prescribing xerostomic medications to people with dementia, and the need for regular and ongoing dental care.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Lexomboon D, Tan EC, Höijer J, et al. The Effect of Xerostomic Medication on Oral Health in Persons With Dementia. J Am Med Dir Assoc. 2018. PMID: 29983362. doi:10.1016/j.jamda.2018.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。